KYANNE WRIGHT: Open Payments
NPI 1649991316 · MERIDIAN, ID. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$496 in 24 payments from 14 companies in 2025. Trend: 2023 $1,268 · 2024 $523 · 2025 $496
Food & beverage: $496
| Company | Payments | Amount |
|---|---|---|
| Corium, LLC | 3 | $58 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $57 |
| ABBVIE INC. | 3 | $52 |
| Teva Pharmaceuticals USA, Inc. | 2 | $50 |
| Otsuka America Pharmaceutical, Inc. | 2 | $44 |
| Alkermes, Inc. | 2 | $43 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $39 |
| Vanda Pharmaceuticals Inc. | 1 | $34 |
| E.R. Squibb & Sons, L.L.C. | 1 | $28 |
| Janssen Pharmaceuticals, Inc | 1 | $23 |
Products named: Azstarys, CAPLYTA, VRAYLAR, AUSTEDO XR, REXULTI, TRINTELLIX, FANAPT, COBENFY.
Industry payments across ID — which companies pay providers there.
